Abstract
The interaction of malaria parasites with their human host is extensively studied, yet only few studies reported how P. falciparum infection affects urinary metabolite profiles and how this is associated with immunity. We present a longitudinal study of the urinary metabolic profiles of twenty healthy Africans with lifelong exposure to malaria and five malaria-naïve Europeans, who were all challenged with direct venous inoculation of live P. falciparum sporozoïtes (PfSPZ) and followed up until they developed symptoms or became thick blood smear positive (TBS). Urine samples were collected before and at 2, 5, 9 and 11 days post challenge and were analysed. Upon infection, all Europeans became TBS positive, while Africans showed either a delay in time to parasitaemia or controlled infection. Our metabolic data showed that Europeans and Africans had distinct alterations in metabolite patterns, with changes mostly seen on days 5 and 9 post PfSPZ infection, and more prominently in Europeans. Within the African group, the levels of formate, urea, trimethylamine, threonine, choline, myo-inositol and acetate were significantly higher in TBS positive whereas the levels of pyruvate, 3-methylhistidine and dimethylglycine were significantly lower in individuals who remained TBS negative. Notably, before inoculation with PfSPZ, a group of metabolites including phenylacetylglutamine can potentially be used to predict parasitaemia control among Africans. Taken together, this study highlights the difference in urinary metabolic changes in response to malaria infection as a consequence of lifelong exposure to malaria and that change detectable before challenge might predict the control of parasitaemia in malaria-endemic areas.
Original language | English |
---|---|
Article number | 1224 |
Pages (from-to) | 1-13 |
Number of pages | 13 |
Journal | Metabolites |
Volume | 12 |
Issue number | 12 |
Early online date | 6 Dec 2022 |
DOIs | |
Publication status | Published - Dec 2022 |
Bibliographical note
Special Issue: Urinary Metabolomics: A New Journey for Biomarker Discovery.Funding Information:
This work was supported by the Horizon 2020 Framework Programme in the form of a grant (WISE PSIA2020AGDG-3316) for student allowance awarded to M.E.B.O. This work was also supported by the Deutsches Zentrum für Infektionsforschung (German Centre for Infection Research (DZIF-CRG)) project grant (TTU 03.703) awarded to A.A.A. This project also received funding from the Bontius Stichting to M.Y., the Stichting Tabernaleporis to M.Y., Leiden University Medical Center Strategic Fund for Leiden Controlled Human Infection Center to M.Y., and the European Union Seventh Framework Programme (FP7 Research Potential of Convergence Regions) for research, technological development and demonstration in the form of a grant (602843) awarded to M.Y. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Publisher Copyright:
© 2022 by the authors.
Funding
This work was supported by the Horizon 2020 Framework Programme in the form of a grant (WISE PSIA2020AGDG-3316) for student allowance awarded to M.E.B.O. This work was also supported by the Deutsches Zentrum für Infektionsforschung (German Centre for Infection Research (DZIF-CRG)) project grant (TTU 03.703) awarded to A.A.A. This project also received funding from the Bontius Stichting to M.Y., the Stichting Tabernaleporis to M.Y., Leiden University Medical Center Strategic Fund for Leiden Controlled Human Infection Center to M.Y., and the European Union Seventh Framework Programme (FP7 Research Potential of Convergence Regions) for research, technological development and demonstration in the form of a grant (602843) awarded to M.Y. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Funders | Funder number |
---|---|
Bontius Stichting | |
Seventh Framework Programme | |
European Commission | |
Seventh Framework Programme | |
Stichting Tabernaleporis | |
Leiden University Medical Center Strategic Fund for Leiden Controlled Human Infection Center | |
Deutsches Zentrum für Infektionsforschung | |
FP7 Research Potential of Convergence Regions | 602843 |
Horizon 2020 Framework Programme | WISE PSIA2020AGDG-3316 |
DZIF-CRG | TTU 03.703 |
Keywords
- Gabon
- hydrophilic interaction chromatography-mass spectrometry
- metabolomics
- nuclear magnetic resonance
- Plasmodium falciparum malaria
- urine